Metreleptin for the treatment of lipodystrophy: leading the way among novel therapeutics for this unmet clinical need-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Metreleptin for the treatment of lipodystrophy: leading the way among novel therapeutics for this unmet clinical need

Published:2022-04-12 Issue:6 Volume:38 Page:885-888
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Polyzos Stergios A.¹^ORCID,Mantzoros Christos S.²³^ORCID

Affiliation:

1. First Laboratory of Pharmacology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece

2. Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA

3. Department of Medicine, Boston VA Healthcare System, Harvard Medical School, Boston, MA, USA

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2022.2059974

Reference28 articles.

1. Positional cloning of the mouse obese gene and its human homologue

2. Leptin in Health and Disease: Facts and Expectations at its Twentieth Anniversary

3. Leptin Receptor Signaling and Action in the Central Nervous System

4. Immunohistochemical Localization of Leptin and Uncoupling Protein in White and Brown Adipose Tissue1

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Obesity in adults;The Lancet;2024-09

2. Circulating leptin in patients with nonalcoholic fatty liver disease‐related liver fibrosis: a systematic review and a meta‐analysis;Journal of Gastroenterology and Hepatology;2024-01-18

3. Preclinical, randomized phase 1, and compassionate use evaluation of REGN4461, a leptin receptor agonist antibody for leptin deficiency;Science Translational Medicine;2023-11-22

4. Leptin Reduction as a Required Component for Weight Loss;Diabetes;2023-11-07

5. The World Congress of Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC);Journal of Diabetes;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3